Premium
Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin
Author(s) -
Cooper Nichola,
Davies E. Graham,
Thrasher Adrian J.
Publication year - 2009
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.2009.07715.x
Subject(s) - medicine , rituximab , autoimmune lymphoproliferative syndrome , neutropenia , autoimmune thrombocytopenia , hepatosplenomegaly , immunology , hematology , autoimmune hemolytic anemia , lymphoproliferative disorders , thrombocytopenic purpura , population , cytopenia , lymphoma , gastroenterology , antibody , chemotherapy , immune system , fas receptor , apoptosis , biochemistry , chemistry , disease , environmental health , programmed cell death , bone marrow